National Survey on Infiltrative Breast Cancer
NCT00696527 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2010-12-10
Summary
The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.
Conditions
- Infiltrative Breast Cancer
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Alain Castaigne, Medical Director · AstraZeneca
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- France
Study Locations
More Related Trials
-
InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2
NCT05835739 ·Status: RECRUITING
-
Role of the Immune Environment in Response to Therapy in Breast Cancer
NCT05396612 ·Status: RECRUITING
-
Follow-up in Early and Locally Advanced Breast Cancer Patients
NCT03859453 ·Status: COMPLETED
-
Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study
NCT02514499 ·Status: COMPLETED ·Phase: NA
-
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014 ·Status: COMPLETED
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT02997384 ·Status: UNKNOWN
-
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
NCT03870802 ·Status: RECRUITING
-
Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer
NCT00293865 ·Status: COMPLETED ·Phase: NA
-
Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
NCT05809128 ·Status: UNKNOWN
-
Involvement of the Inositol-trisphosphate Receptor in Invasive or Migratory-type Breast Cancers
NCT03107234 ·Status: UNKNOWN
-
Locoregional Recurrence of Breast Cancer
NCT05988112 ·Status: NOT_YET_RECRUITING
-
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
NCT03667417 ·Status: RECRUITING
-
IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)
NCT04012229 ·Status: COMPLETED
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN
-
Study in Leptomeningeal Metastases of Breast Cancer
NCT03252912 ·Status: COMPLETED ·Phase: NA
-
Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cm
NCT00636467 ·Status: COMPLETED ·Phase: PHASE2
-
SENOVIE France - Therapeutic Mobility and Breast Cancer
NCT06503393 ·Status: COMPLETED
-
New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement
NCT02926547 ·Status: COMPLETED
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
NCT00666731 ·Status: COMPLETED
-
Prospective Radiomics Study for Breast Cancer
NCT06095414 ·Status: COMPLETED
-
Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse
NCT03630653 ·Status: TERMINATED ·Phase: NA
-
Predictive Clinical and Biological Parameters in Breast Cancer
NCT01521676 ·Status: TERMINATED ·Phase: NA